Compass Therapeutics Inc.

NASDAQ CMPX

Data sourced from iex and EODHD
Download Data

Compass Therapeutics Inc. Cash Flow Statement 2018 - 2023

This table shows the Cash Flow Statement for Compass Therapeutics Inc. going from 2018 until 2023. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Net Income
M -42 -39 -82 -30 -35 -38
Depreciation and Amortization
M 2 2 2 2 2 2
Non-Cash Items (Other)
M 6 -1 0 -1 0 0
Operating Cash Flow
M -41 -34 -20 -27 -32 -34
Capital Expenditures
M 0 0 -2 0 0 -2
Net Acquisitions
M - - - - - -
Other Investing Activities
M - 0 0 0 - -
Investing Cash Flow
M - 0 0 0 - -
Repayment/Issuance of Debt (Net)
M - - -9 -6 -6 15
Equity Repurchase (Common, Net)
M 0 76 128 54 - -
Dividends Paid
M - - - - - -
Other Financial Activities
M 0 0 0 -6 0 64
Financing Cash Flow
M 0 0 0 -6 0 64
Exchange Rate Adjustment
M - - - - - -
Beginning Cash
M 35 145 47 26 58 29
Ending Cash
M 24 35 145 47 26 58
Stock-Based Compensation
M 6 5 4 4 1 1
Issuance/Purchase of Shares
M 0 76 128 54 - -
Capital Stock Change
M 3 76 128 60 0 49
Working Capital
M 146 179 136 40 16 50
Free Cash Flow
M -41 -34 -21 -27 -32 -36

StockViz Staff

September 19, 2024

Any question? Send us an email